HOME >> BIOLOGY >> NEWS
Oxford Journals takes bold step towards free access to research

Oxford Journals, a Division of Oxford University Press (OUP), announced today that its flagship journal Nucleic Acids Research (NAR) is to move to a full 'Open Access' (OA) publishing model from January 2005. This represents a significant step towards maximum dissemination of scholarly research, a core part of OUP's mission as a leading University-owned Press.

NAR will adopt a mandatory OA model whereby authors pay a fee once their paper has been accepted, and all articles published online are immediately available without charge.

NAR is a highly respected journal, listed by ISI as one of the top ten 'hottest' journals of the decade in biology and biochemistry , and with a world-renowned editorial team. It has been published under a subscription model for 32 years and includes around 1000 original research papers per year, making NAR the first journal of such stature to make a complete switch from a subscription to OA model.

"Open Access is undoubtedly the most debated topic in scholarly publishing at the moment. To fulfil our role as a University Press we felt a responsibility to the scholarly communities we represent to explore it as a viable publishing model," explained Martin Richardson, Managing Director of Oxford Journals. "Our year-long experiments with a small part of NAR have allowed us to consult authors, readers, and librarians on their views and also to monitor results. So our decision to take NAR to a full Open Access model is based on solid research, and a clear desire for such a move by this part of the academic community."

The OA model being adopted for NAR has been designed to address various concerns raised in the OA debate thus far, as well as to safeguard the quality and financial viability of the journal. The model, which includes a mixture of author charges, institutional memberships and print subscriptions, as well as significantly lower (or no) charges for authors in deve
'"/>

Contact: Rachel Goode
rachel.goode@oupjournals.org
44-7957-491-505
Oxford University Press
28-Jun-2004


Page: 1 2 3 4 5

Related biology news :

1. Open Access Initiative from Oxford Journals
2. Tips from the Journals of the American Society for Microbiology
3. Tips from the Journals of the American Society for Microbiology
4. Tips from the Journals of the American Society for Microbiology
5. Tips from the Journals of the American Society for Microbiology
6. Tips from the Journals of the American Society for Microbiology
7. Tips from the Journals of the American Society for Microbiology
8. Tips from the Journals of the American Society for Microbiology
9. Tips from the Journals of the American Society for Microbiology
10. Tips from the Journals of the American Society for Microbiology
11. Tips from the Journals of the American Society for Microbiology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with ... Check local listings for more info. , Today, the majority of testing is performed ... throughout the country. Results are then available several days later. Now, in an effort ...
(Date:6/23/2020)... THE WOODLNDS, Texas (PRWEB) , ... June 23, ... ... in X-ray analytical instrumentation, is pleased to announce the next event in a ... of X-ray scattering. , The TOPIQ series of webinars was developed in response ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, ... surgery is only the beginning of a successful study, while protecting and accessing the ... Gien, Global Head of Surgery from Envigo in a live webinar ...
(Date:7/10/2020)... , ... July 08, 2020 , ... ... and products, announces a significant expansion of laboratory operations through its COVID-19 ... agencies implementing testing programs. , Bode-CARES provides a turnkey solution ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in Mexico ... patient's condition, treatment may be offered IV, intrathecal or with a combination. , A ... and the incidence continues to increase as individuals live longer. There is no cure, ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
Breaking Biology Technology:
Cached News: